Provided by Tiger Fintech (Singapore) Pte. Ltd.

ReShape Lifesciences, Inc.

5.98
-0.0700-1.16%
Volume:15.17K
Turnover:89.06K
Market Cap:4.42M
PE:-0.02
High:6.05
Open:5.99
Low:5.75
Close:6.05
Loading ...
May 09, 2025

Major Issues Report

Form 8-K - Current report
Apr 29, 2025

Major Issues Report

Form 8-K - Current report
Apr 21, 2025

Major Issues Report

Form 8-K - Current report
Apr 21, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 04, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Feb 21, 2025

Major Issues Report

Form 8-K - Current report
Feb 15, 2025

Correspondence

Form CORRESP - Correspondence
Feb 14, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 14, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 14, 2025

Correspondence

Form CORRESP - Correspondence
Feb 13, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 13, 2025

Correspondence

Form CORRESP - Correspondence
Feb 07, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 06, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 21, 2025

Major Issues Report

Form 8-K - Current report
Jan 21, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 15, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 15, 2025

Correspondence

Form CORRESP - Correspondence